Inclusive of all taxes
Tranexamic Acid Tablets IP 500 mg is a high-quality pharmaceutical product specifically formulated for the treatment and management of gynecology-related conditions, including heavy menstrual bleeding and other hemorrhagic disorders. This formulation ensures a precise 500 mg dosage of Tranexamic Acid per tablet, delivering consistent therapeutic efficacy. Manufactured under stringent WHO-GMP standards at IndiGlobal Exports, these tablets comply with Indian Pharmacopoeia (IP) and other international regulatory norms, making them ideal for export and global pharmaceutical markets. The tablets are presented in export-grade blister or strip packs that facilitate bulk supply and maintain product stability throughout the shelf life. Designed for reliable hemostatic activity, Tranexamic Acid Tablets IP 500 mg effectively inhibit fibrinolysis, promoting blood clot stability, which is crucial in gynecological therapies. This product is widely used in hospital settings, clinics, and retail pharmacies, particularly for managing conditions such as menorrhagia, uterine bleeding, and other bleeding disorders associated with gynecology. Its consistent quality and compliance with export standards make it a preferred choice for healthcare providers and distributors seeking dependable and safe antifibrinolytic therapy solutions.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Tranexamic Acid 500 mg per tablet |
| Indication | Management of gynecological bleeding disorders |
| Dosage Form | Tablet |
| Packaging | Export-grade blister or strip packs |
| Manufacturing Standards | WHO-GMP compliant facilities |
| Pharmacopoeial Compliance | Indian Pharmacopoeia (IP) standards |
| Therapeutic Use | Effective inhibition of fibrinolysis to control bleeding |
| Market Suitability | Approved for international pharmaceutical exports |
| Shelf Life | As per regulatory standards |
| Manufacturer | IndiGlobal Exports |
| Attributes | Description |
|---|---|
| Category | Gynecology |
| Formulation | Tablet |
| Dosage Strength | 500 mg |
| Packaging Type | Blister or strip packs suitable for export |
| Shelf Life | As per regulatory requirements |
| Manufacturing Compliance | WHO-GMP |
| Pharmacopoeial Reference | IP (Indian Pharmacopoeia) |
| Intended Use | Treatment of heavy menstrual bleeding and other gynecological hemorrhages |
| Manufacturer | IndiGlobal Exports |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The tablets are manufactured in WHO-GMP compliant facilities, adhering to Indian Pharmacopoeia standards, with export-grade blister packaging ensuring compliance with international quality and regulatory requirements.
The tablets inhibit fibrinolysis by blocking plasminogen activation, stabilizing blood clots and reducing excessive bleeding associated with gynecological conditions like menorrhagia.
The product is available in secure, export-grade blister or strip packs that maintain the tablet's integrity during transportation and storage for bulk institutional or distributor supply.
Yes, the product is widely accepted and prescribed in hospital settings and retail pharmacies due to its consistent quality and reliable therapeutic profile.
Yes, IndiGlobal Exports manufactures these tablets strictly under WHO-GMP conditions and complies fully with Indian Pharmacopoeia standards, making them suitable for regulated and semi-regulated markets.
Brand: indiglobal exports
Country Of Origin: India
Tranexamic Acid Tablets IP 500 mg is a pharmaceutical product indicated for gynecology treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Tranexamic Acid Tablets IP 500 mg is developed for the effective management of gynecology conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with gynecology indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
